Professional Documents
Culture Documents
10.1111/j.1469-0691.2011.03748.x
However, before generalizing results and deriving solutions for European hospitalizations, some threats to the
validity of the study should be underlined. First, the
researchers were able to determine the causative pathogen
for 56% of the hospitalizations only, and, although the number of unidentified cases was roughly parallel with the number of total cases, this might have introduced a reporting
bias. Second, and more important from an infection control
point of view, distinction between cases caused by MRSA
and methicillin-susceptible S. aureus (MSSA) and definition of
the site of acquisition (community vs. hospital vs. healthcare
facilities) were not possible. The lack of this information prevents public health officers, epidemiologists and infection
control practitioners from analysing the origin of clones and
suggesting future steps for prevention.
However, some hypotheses might be outlined. First, if the
increase has arisen from community-acquired cases, then
possible changes in the outpatient population need to be
ascertained. The rise might be attributed to the increase in
the number of cases caused by intravenous drug usage or, as
I suspect, to the change in the number of immunocompromised patients, mainly in relation to the wide usage of biological agents, as anti-tumour necrosis factor therapies [3].
Another reason for the increase can be derived from the
observation reported by Furuno and coworkers on the US
human immunodeficiency virus population. The authors
observed that community-acquired MRSA was significantly
associated with an increased incidence of endocarditis in a
cohort of human immunodeficiency virus patients with MRSA
bacteraemia [4]. A better understanding of the population in
which the increase in endocarditis was observed would allow
the development of infection control measures and prevention therapies that differ according to patients comorbidities
and type of immunosuppression. We should also take into
consideration that the rise in S. aureus endocarditis could be
a consequence of the circulation of different strains [5]. For
example, in the reduction of the MRSA epidemic that was
observed in the UK, the marked decline was associated, in
particular, with one of the clones that previously dominated
the epidemic (sequence type (ST)36) [6,7]. On the other
108
CMI
Transparency Declaration
None.
References
1. Tacconelli E. The management of methicillin-resistant Staphylococcus
aureus infection in Europe. Clin Microbiol Infect 2010; 16 (suppl 1): 1
2.
2. Boyce T, Murray E, Holmes A. What are the drivers of the UK
media coverage of meticillin-resistant Staphylococcus aureus, the interrelationships and relative influences? J Hosp Infect 2009; 73: 400407.
3. Winthrop KL, Chiller T. Preventing and treating biologic-associated
opportunistic infections. Nat Rev Rheumatol 2009; 5: 405410.
4. Furuno JP, Johnson JK, Schweizer ML et al. Community-associated
methicillin-resistant Staphylococcus aureus bacteremia and endocarditis
among HIV patients: a cohort study. BMC Infect Dis 2011; 11: 298304.
5. Wyllie D, Paul J, Crook D. Waves of trouble: MRSA strain dynamics
and assessment of the impact of infection control. J Antimicrob Chemother 2011; 66: 26852688.
6. Wyllie DH, Walker AS, Miller R et al. Decline of meticillin-resistant
Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification. BMJ Open 2011; 1: e000160.
7. Ellington MJ, Hope R, Livermore DM et al. Decline of EMRSA-16
amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 2010;
65: 446448.
8. Anderson DJ, Arduino JM, Reed SD et al. Variation in the type and
frequency of postoperative invasive Staphylococcus aureus infections
according to type of surgical procedure. Infect Control Hosp Epidemiol
2010; 31: 701709.
9. Cataldo MA, Petrosillo N, Cipriani M, Cauda R, Tacconelli E. Prosthetic joint infection: recent developments in diagnosis and management. J Infect 2010; 61: 443448.
10. Gagliotti C, Balode A, Baquero F et al. EARS-Net Participants (Disease Specific Contact Points for AMR). Escherichia coli and Staphylococcus aureus: bad news and good news from the European
CMI
109